14-day Premium Trial Subscription Try For FreeTry Free
$1.20
+0.0100 (+0.84%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 APTO stock ended at $1.20. This is 0.84% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.36% from a day low at $1.19 to a day high of $1.23.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Aptose Biosciences prices

Date Open High Low Close Volume
May 04, 2023 $0.540 $0.540 $0.510 $0.522 150 699
May 03, 2023 $0.546 $0.549 $0.512 $0.529 191 270
May 02, 2023 $0.534 $0.580 $0.531 $0.550 173 497
May 01, 2023 $0.497 $0.550 $0.475 $0.550 390 798
Apr 28, 2023 $0.474 $0.486 $0.474 $0.483 258 638
Apr 27, 2023 $0.499 $0.499 $0.474 $0.474 217 720
Apr 26, 2023 $0.500 $0.500 $0.470 $0.474 135 482
Apr 25, 2023 $0.490 $0.498 $0.460 $0.480 128 311
Apr 24, 2023 $0.475 $0.498 $0.475 $0.482 77 038
Apr 21, 2023 $0.464 $0.500 $0.464 $0.485 114 635
Apr 20, 2023 $0.495 $0.511 $0.480 $0.480 187 255
Apr 19, 2023 $0.490 $0.520 $0.490 $0.500 263 987
Apr 18, 2023 $0.513 $0.519 $0.493 $0.506 103 924
Apr 17, 2023 $0.500 $0.523 $0.490 $0.510 220 916
Apr 14, 2023 $0.540 $0.548 $0.511 $0.512 109 581
Apr 13, 2023 $0.510 $0.546 $0.500 $0.514 298 051
Apr 12, 2023 $0.560 $0.560 $0.502 $0.525 245 772
Apr 11, 2023 $0.533 $0.553 $0.460 $0.540 689 306
Apr 10, 2023 $0.560 $0.560 $0.530 $0.550 120 692
Apr 06, 2023 $0.590 $0.600 $0.540 $0.550 192 050
Apr 05, 2023 $0.620 $0.640 $0.580 $0.600 163 078
Apr 04, 2023 $0.612 $0.630 $0.590 $0.613 188 084
Apr 03, 2023 $0.650 $0.650 $0.623 $0.640 40 143
Mar 31, 2023 $0.640 $0.655 $0.622 $0.640 150 960
Mar 30, 2023 $0.660 $0.660 $0.610 $0.634 71 563
Click to get the best stock tips daily for free!

About Aptose Biosciences

Aptose Biosciences Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Ph... APTO Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT